Provides that the prescription label for medication abortion prescription drugs shall include the name of the dispensing health care practice instead of the name of the dispenser.
Summary
H6174 amends Rhode Island’s Protections for Healthcare Providers Act to change how prescription labels are completed for medication abortion drugs. Under the bill, the label for medication abortion prescription drugs must list the name of the dispensing healthcare practice rather than the name of the individual dispenser. The bill defines medication abortion prescription drugs as substances used to induce the termination of a pregnancy, including mifepristone and misoprostol.
The measure is framed as a provider-protection and privacy-related change for legal healthcare activity. It would apply specifically to abortion medication prescriptions and would take effect immediately upon passage. By shifting the identifying information on the label from an individual dispenser to the healthcare practice, the bill would alter labeling requirements for pharmacies, clinics, and other dispensing entities involved in medication abortion care.
Impact
If enacted, the bill would amend chapter 5-37.8 of the Rhode Island General Laws by adding a new section governing prescription labeling for medication abortion drugs. It would require dispensing entities to use the healthcare practice’s name on the prescription label instead of the dispenser’s name, potentially affecting pharmacy labeling procedures, provider identification practices, and privacy protections for staff involved in abortion-related care. The change would be limited to medication abortion prescription drugs and would not broadly revise prescription labeling rules for other medications.
Sentiment
No committee transcript or recorded vote information was provided, so there is no documented debate or vote history to assess. Based on the bill text and caption, the measure appears to be supported as a healthcare provider protection and privacy measure, but the available record does not show formal sentiment from committee members or the chamber.
Contention
The main likely point of contention is the bill’s focus on medication abortion, which may draw differing views based on abortion policy rather than on prescription-labeling mechanics alone. Supporters would likely emphasize provider privacy, safety, and protection of legal healthcare activity, while opponents may object to the special treatment of abortion-related prescriptions or to reducing individual dispenser identification on labels. No specific objections or sponsors’ arguments are included in the provided materials.